QNRX
Quoin Pharmaceuticals, Ltd.NASDAQHealthcare$7.02+15.84%ClosedMarket Cap: $4.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.52
P/S
0.00
EV/EBITDA
233.73
DCF Value
$3,573.95
FCF Yield
-358.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-310165.1%
ROA
-77509.6%
ROIC
-0.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-4.6M | $-15.79B | $-14,776.76 | — |
| FY 2025 | $0.00 | -Infinity% | $-16.4M | $-15.80B | $-14,796.26 | — |
| Q3 2025 | $0.00 | NaN% | $-4.0M | $-3.9M | $-6.71 | — |
| Q2 2025 | $0.00 | NaN% | $-3.8M | $-3.7M | $-6.28 | — |
| Q1 2025 | $0.00 | NaN% | $-4.0M | $-3.8M | $-6.50 | — |
| Q4 2024 | $0.00 | NaN% | $-2.4M | $-2.3M | $-12.41 | — |
| FY 2024 | $0.00 | NaN% | $-9.5M | $-9.0M | $-66.85 | — |
| Q3 2024 | $0.00 | NaN% | $-2.5M | $-2.3M | $-16.45 | — |
| Q2 2024 | $0.00 | NaN% | $-2.1M | $-2.0M | $-0.39 | — |
| Q1 2024 | $0.00 | NaN% | $-2.5M | $-2.3M | $-1.12 | — |
| Q4 2023 | $0.00 | NaN% | $-2.2M | $-2.0M | $-2.10 | — |
| FY 2023 | $0.00 | NaN% | $-9.4M | $-8.7M | $-337.47 | — |